Literature DB >> 19192757

Long-term extracorporeal circulation management: the role of low- and high-range heparin ACT tests.

Daniel Herbst1, Hani K Najm, Kumar Neerod Jha.   

Abstract

Modern management of extracorporeal circulation, especially during long-term support of post-cardiac surgical patients, remains challenging and requires optimal care of the patient's fluid balance and coagulation hemostasis for its successful outcome. The activated clotting time assay is one of the tests used to manage extracorporeal circulation and is available in a low- and high-range level. The question of which assay is more appropriate for procedures that require low to moderate heparin dosing is still unclear. We report our experience with a neonate diagnosed with hypoplastic left heart syndrome who needed emergent extracorporeal membrane oxygenation support for 13 days after Norwood stage I palliation using a Sano shunt. Although successful, bleeding complications prompted us to review our strategy for management of coagulation hemostasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19192757      PMCID: PMC4680717     

Source DB:  PubMed          Journal:  J Extra Corpor Technol        ISSN: 0022-1058


  7 in total

1.  Quantitative evaluation of hypothermia, hyperthermia, and hemodilution on coagulation.

Authors:  S A Kmiecik; J L Liu; T S Vaadia; J D Nichols; R J Kohtz; N J Mills; C M Petterson; A H Stammers
Journal:  J Extra Corpor Technol       Date:  2001-05

2.  The effects of cardiopulmonary bypass with hollow fiber membrane oxygenator on blood clotting measured by thromboelastography.

Authors:  M Horácek; K Cvachovec
Journal:  Physiol Res       Date:  2002       Impact factor: 1.881

3.  Coagulation monitoring during extracorporeal membrane oxygenation: the role of thrombelastography.

Authors:  A H Stammers; L Willett; L Fristoe; J Merrill; T Stover; A Hunt; J Morrow; J Newberry
Journal:  J Extra Corpor Technol       Date:  1995-09

4.  Hemostasis changes during cardiopulmonary bypass surgery.

Authors:  E F Mammen; M H Koets; B C Washington; L W Wolk; J M Brown; M Burdick; N R Selik; R F Wilson
Journal:  Semin Thromb Hemost       Date:  1985-07       Impact factor: 4.180

5.  Heparin detection by the activated coagulation time: a comparison of the sensitivity of coagulation tests and heparin assays.

Authors:  D J Murray; W J Brosnahan; B Pennell; D Kapalanski; J M Weiler; J Olson
Journal:  J Cardiothorac Vasc Anesth       Date:  1997-02       Impact factor: 2.628

Review 6.  Platelet function in cardiopulmonary bypass and artificial organs.

Authors:  V P Addonizio
Journal:  Hematol Oncol Clin North Am       Date:  1990-02       Impact factor: 3.722

7.  Heparin monitoring during cardiopulmonary bypass.

Authors:  A Saleem; S S Shenaq; D H Yawn; K Harshberger; P Diemunsch; P Mohindra
Journal:  Ann Clin Lab Sci       Date:  1984 Nov-Dec       Impact factor: 1.256

  7 in total
  1 in total

1.  Ventilatory and ECMO treatment of H1N1-induced severe respiratory failure: results of an Italian referral ECMO center.

Authors:  Giovanni Cianchi; Manuela Bonizzoli; Andrea Pasquini; Massimo Bonacchi; Giovanni Zagli; Marco Ciapetti; Guido Sani; Stefano Batacchi; Simona Biondi; Pasquale Bernardo; Chiara Lazzeri; Valtere Giovannini; Alberta Azzi; Rosanna Abbate; Gianfranco Gensini; Adriano Peris
Journal:  BMC Pulm Med       Date:  2011-01-11       Impact factor: 3.317

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.